Hofseth Biocare ASA (OL:HBC) — Stock Price
Hofseth Biocare ASA (OL:HBC) is currently trading at Nkr1.34 NOK, down 1.11% today. Over the past 52 weeks, shares have ranged between Nkr1.12 and Nkr2.08. This page tracks Hofseth Biocare ASA's live share price on the OL exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Hofseth Biocare ASA (HBC) market capitalisation.
Hofseth Biocare ASA (HBC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Hofseth Biocare ASA's daily closing share price and trading volume on the OL exchange over the past year, giving a clear view of recent price momentum and liquidity.
Hofseth Biocare ASA Income Statement — Revenue, Profit & Earnings by Year
Hofseth Biocare ASA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Nkr257.42 Million | Nkr194.87 Million | Nkr120.45 Million | Nkr87.62 Million | Nkr69.25 Million |
| Cost of Revenue | Nkr169.55 Million | Nkr150.69 Million | Nkr91.93 Million | Nkr64.52 Million | Nkr39.53 Million |
| Gross Profit | Nkr87.86 Million | Nkr44.19 Million | Nkr28.51 Million | Nkr23.10 Million | Nkr29.72 Million |
| Research & Development | Nkr14.98 Million | Nkr11.01 Million | Nkr13.63 Million | Nkr12.53 Million | Nkr7.56 Million |
| SG&A | Nkr27.65 Million | Nkr21.99 Million | Nkr17.87 Million | Nkr31.82 Million | Nkr18.67 Million |
| Total Operating Expenses | Nkr96.47 Million | Nkr146.72 Million | Nkr157.13 Million | Nkr141.66 Million | Nkr121.83 Million |
| Operating Income | Nkr-113.98 Million | Nkr-102.53 Million | Nkr-128.62 Million | Nkr-118.56 Million | Nkr-92.02 Million |
| EBITDA | Nkr-68.01 Million | Nkr-62.73 Million | Nkr-97.01 Million | Nkr-87.72 Million | Nkr-69.07 Million |
| EBIT | Nkr-102.13 Million | Nkr-99.14 Million | Nkr-127.23 Million | Nkr-117.07 Million | Nkr-92.88 Million |
| Interest Expense | Nkr15.69 Million | Nkr7.54 Million | Nkr9.95 Million | Nkr9.39 Million | Nkr9.21 Million |
| Income Before Tax | Nkr-125.30 Million | Nkr-106.68 Million | Nkr-137.39 Million | Nkr-126.46 Million | Nkr-102.09 Million |
| Income Tax Expense | — | — | Nkr1.18 Million | — | Nkr-1.01 Million |
| Net Income | Nkr-123.41 Million | Nkr-106.68 Million | Nkr-137.39 Million | Nkr-126.46 Million | Nkr-102.09 Million |
Hofseth Biocare ASA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Hofseth Biocare ASA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Nkr341.37 Million | Nkr390.12 Million | Nkr411.03 Million | Nkr415.97 Million | Nkr459.13 Million |
| Total Current Assets | Nkr112.06 Million | Nkr131.00 Million | Nkr175.75 Million | Nkr170.31 Million | Nkr271.47 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Nkr21.46 Million | Nkr14.85 Million | Nkr14.07 Million | Nkr22.43 Million | Nkr21.08 Million |
| Inventory | Nkr55.92 Million | Nkr82.54 Million | Nkr116.53 Million | Nkr90.81 Million | Nkr73.30 Million |
| Property, Plant & Equipment | Nkr137.98 Million | Nkr165.70 Million | Nkr168.79 Million | Nkr185.83 Million | Nkr137.96 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Nkr280.07 Million | Nkr348.98 Million | Nkr263.00 Million | Nkr275.60 Million | Nkr195.37 Million |
| Total Current Liabilities | Nkr168.42 Million | Nkr251.88 Million | Nkr172.23 Million | Nkr150.93 Million | Nkr106.18 Million |
| Long-term Debt | Nkr25.10 Million | Nkr271.00K | Nkr812.00K | Nkr23.79 Million | Nkr25.11 Million |
| Net Debt | Nkr145.30 Million | Nkr259.92 Million | Nkr74.29 Million | Nkr91.97 Million | Nkr-69.87 Million |
| Total Stockholder Equity | Nkr60.05 Million | Nkr41.83 Million | Nkr148.72 Million | Nkr141.06 Million | Nkr264.45 Million |
| Retained Earnings | Nkr0.00 | Nkr0.00 | Nkr145.73 Million | Nkr139.19 Million | Nkr15.48 Million |
Hofseth Biocare ASA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Hofseth Biocare ASA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Nkr-9.78 Million | Nkr2.76 Million | Nkr-45.17 Million | Nkr-61.78 Million | Nkr-61.63 Million |
| Capital Expenditures | Nkr4.07 Million | Nkr8.19 Million | Nkr17.78 Million | Nkr37.75 Million | Nkr54.46 Million |
| Free Cash Flow | Nkr-13.89 Million | Nkr-11.30 Million | Nkr-62.95 Million | Nkr-99.53 Million | Nkr-116.09 Million |
| Investing Cash Flow | Nkr-4.07 Million | Nkr-14.99 Million | Nkr-17.78 Million | Nkr-37.94 Million | Nkr-60.06 Million |
| Financing Cash Flow | Nkr15.58 Million | Nkr3.70 Million | Nkr45.45 Million | Nkr-23.20 Million | Nkr199.97 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Nkr39.78 Million | Nkr36.41 Million | Nkr30.41 Million | Nkr29.35 Million | Nkr26.77 Million |
| Change in Cash | Nkr1.69 Million | Nkr-8.54 Million | Nkr-17.49 Million | Nkr-122.91 Million | Nkr78.28 Million |
Hofseth Biocare ASA Earnings History — EPS Actual vs. Analyst Estimates
Track Hofseth Biocare ASA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -0.07 | — | — |
| Jun 30, 2025 | -0.06 | — | — |
| May 09, 2025 | -0.08 | — | — |
| Feb 14, 2025 | -0.10 | — | — |
| Nov 08, 2024 | -0.09 | — | — |
| Aug 23, 2024 | -0.04 | — | — |
| May 10, 2024 | -0.07 | — | — |
| Jan 04, 2024 | -0.13 | — | — |